tiprankstipranks
Lakefront Biotherapeutics NV (MX:GLPGN)
:GLPGN
Mexico Market
GLPGN
Lakefront Biotherapeutics NV
RESEARCH TOOLSreports

Lakefront Biotherapeutics NV (GLPGN) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

GLPGN Analyst Ratings

Moderate Sell
2Ratings
Moderate Sell
0 Buy
1 Hold
1 Sell
Based on 2 analysts giving stock ratings to
Lakefront
Biotherapeutics NV
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GLPGN Stock 12 Month Forecast

Average Price Target

$492.49
Based on 2 Wall Street analysts offering 12 month price targets for Lakefront Biotherapeutics NV in the last 3 months. The average price target is $492.49 with a high forecast of $550.72 and a low forecast of $434.26. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$550.72Average Price Target$492.49Lowest Price Target$434.26
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on MX:GLPGN
James Gordon CFA
Barclays
Barclays
$434.26
Sell
―
Reiterated
09/08/26
Barclays Sticks to Their Sell Rating for Galapagos (0JXZ)
Bernstein Analyst forecast on MX:GLPGN
Delphine Le Louet
Bernstein
Bernstein
$550.72
Hold
―
Reiterated
09/01/26
Bernstein Remains a Hold on Galapagos (0JXZ)
Kepler Capital Analyst forecast on MX:GLPGN
Christophe dombu
Kepler Capital
Kepler Capital
$463.87
Sell
―
Reiterated
05/07/26
Kepler Capital Sticks to Their Sell Rating for Galapagos (0JXZ)
UBS Analyst forecast on MX:GLPGN
Xian Deng
UBS
UBS
$592.17
Hold
―
Reiterated
04/01/26
UBS Reaffirms Their Hold Rating on Galapagos (0JXZ)
Bank of America Securities Analyst forecast on MX:GLPGN
Jason Gerberry
Bank of America Securities
Bank of America Securities
―
Sell
―
Reiterated
11/07/25
Galapagos (0JXZ) Receives a Sell from Bank of America Securities
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on MX:GLPGN
James Gordon CFA
Barclays
Barclays
$434.26
Sell
―
Reiterated
09/08/26
Barclays Sticks to Their Sell Rating for Galapagos (0JXZ)
Bernstein Analyst forecast on MX:GLPGN
Delphine Le Louet
Bernstein
Bernstein
$550.72
Hold
―
Reiterated
09/01/26
Bernstein Remains a Hold on Galapagos (0JXZ)
Kepler Capital Analyst forecast on MX:GLPGN
Christophe dombu
Kepler Capital
Kepler Capital
$463.87
Sell
―
Reiterated
05/07/26
Kepler Capital Sticks to Their Sell Rating for Galapagos (0JXZ)
UBS Analyst forecast on MX:GLPGN
Xian Deng
UBS
UBS
$592.17
Hold
―
Reiterated
04/01/26
UBS Reaffirms Their Hold Rating on Galapagos (0JXZ)
Bank of America Securities Analyst forecast on MX:GLPGN
Jason Gerberry
Bank of America Securities
Bank of America Securities
―
Sell
―
Reiterated
11/07/25
Galapagos (0JXZ) Receives a Sell from Bank of America Securities
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lakefront Biotherapeutics NV

3 Months
Christophe dombuKepler Capital
Success Rate
6/12 ratings generated profit
50%
Average Return
-2.89%
Copying Christophe dombu's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -2.89% per trade.
1 Year
Christophe dombuKepler Capital
Success Rate
5/12 ratings generated profit
42%
Average Return
-0.54%
Copying Christophe dombu's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of -0.54% per trade.
2 Years
Christophe dombuKepler Capital
Success Rate
6/12 ratings generated profit
50%
Average Return
+1.57%
Copying Christophe dombu's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +1.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GLPGN Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
2
1
0
0
1
Sell
5
3
2
1
2
Strong Sell
0
0
0
0
0
total
7
4
2
1
3
In the current month, GLPGN has received 0 Buy Ratings, 1 Hold Ratings, and 2 Sell Ratings. GLPGN average Analyst price target in the past 3 months is 492.49.
Each month's total comprises the sum of three months' worth of ratings.

GLPGN Financial Forecast

GLPGN Earnings Forecast

Next quarter’s earnings estimate for GLPGN is -$13.83 with a range of -$31.68 to $4.53. The previous quarter’s EPS was $0.59. GLPGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year GLPGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for GLPGN is -$13.83 with a range of -$31.68 to $4.53. The previous quarter’s EPS was $0.59. GLPGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year GLPGN has Performed in-line its overall industry.

GLPGN Sales Forecast

Next quarter’s sales forecast for GLPGN is $151.66M with a range of $90.52M to $216.46M. The previous quarter’s sales results were $238.31M. GLPGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year GLPGN has Performed in-line its overall industry.
Next quarter’s sales forecast for GLPGN is $151.66M with a range of $90.52M to $216.46M. The previous quarter’s sales results were $238.31M. GLPGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year GLPGN has Performed in-line its overall industry.

GLPGN Stock Forecast FAQ

What is MX:GLPGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Lakefront Biotherapeutics NV’s 12-month average price target is 492.49.
    What is MX:GLPGN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:GLPGN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Lakefront Biotherapeutics NV a Buy, Sell or Hold?
        Lakefront Biotherapeutics NV has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 1 hold ratings and 1 sell ratings.
          What is Lakefront Biotherapeutics NV’s share price target?
          The average share price target for Lakefront Biotherapeutics NV is 492.49. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $550.72 ,and the lowest forecast is $434.26. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Lakefront Biotherapeutics NV?
            Lakefront Biotherapeutics NV’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 2 Wall Streets Analysts.
              How can I buy shares of Lakefront Biotherapeutics NV?
              To buy shares of MX:GLPGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.